
China SXT Pharmaceuticals SXTC
€ 0.08
-5.4%
Geschäftsbericht 2025
hinzugefügt 17.01.2026
China SXT Pharmaceuticals Betriebszyklus 2011-2026 | SXTC
Betriebszyklus Jährlich China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 216 | 176 | 183 | 254 | 483 | 424 | 185 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 483 | 176 | 274 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Adagene
ADAG
|
53.8 | $ 2.62 | 28.82 % | $ 147 M | ||
|
GlaxoSmithKline plc
GSK
|
0.02 | $ 48.98 | 0.68 % | $ 173 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 9.25 | 1.49 % | $ 6.83 B | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
149 | $ 34.61 | 0.61 % | $ 2.69 B | ||
|
Zoetis
ZTS
|
379 | $ 123.99 | -0.31 % | $ 56.3 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 67.49 | -3.02 % | $ 9.03 B | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
195 | $ 25.92 | -0.86 % | $ 1.26 B | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 13.49 | -0.66 % | $ 4.17 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.66 | -1.85 % | $ 16.7 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 92.87 | 1.28 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
452 | $ 171.89 | -1.1 % | $ 25 B |